Due to the rapidly expanding repertoire of tests being delivered by the Cancer Team, I am very pleased to announce that Holly Lewis has been appointed as a Section Lead, joining Sally Spillane, Helen Roberts and Sheila Palmer-Smith. Between them they will be delivering the following cancer genomic services:
This email address is being protected from spambots. You need JavaScript enabled to view it.: CRUK project, Lung Cancer, Breast Cancer, Sarcomas and Tissue Identity Service.
This email address is being protected from spambots. You need JavaScript enabled to view it.: Chronic Myeloid Leukaemia, Acute Myeloid Leukaemia, Acute Lymphoblastic Leukaemia, Myelodysplastic Syndromes, Myeloproliferative Syndromes, Mastocytosis and Hairy Cell Leukaemia.
This email address is being protected from spambots. You need JavaScript enabled to view it.: Glioma, Lymphoma, Gastro-Intestinal Tumours, Melanoma, Thyroid Cancer, Myeloma, Chronic Lymphocytic Leukaemia, Chimerisms and Waldenstroms Macroglobinaemia.
This email address is being protected from spambots. You need JavaScript enabled to view it.: Germline Cancer Conditions, Colorectal Cancer (germline and somatic testing) and Ovarian Cancer.
We will keep you updated via email and the websiteas we introduce new services across the cancer section.
Many thanks for your continued support with the service.
Rhian White FRCPath Consultant Clinical Scientist Head of Cancer Genomics
